Radiation Dose
Showing 9976 - 10000 of >10,000
Safety Issues Trial in Norfolk, Thika, Durban (TAF/EVG vaginal insert, Matching Placebo vaginal insert)
Not yet recruiting
- Safety Issues
- TAF/EVG vaginal insert
- Matching Placebo vaginal insert
-
Norfolk, Virginia
- +2 more
Oct 11, 2023
Asthma Trial (BDA MDI, AS MDI)
Not yet recruiting
- Asthma
- BDA MDI
- AS MDI
- (no location specified)
Aug 15, 2022
Advanced Solid Tumor, Clear Cell Renal Cell Carcinoma, Hepatocellular Carcinoma Trial in Korea, Republic of, Singapore, United
Recruiting
- Advanced Solid Tumor
- +3 more
-
Duarte, California
- +22 more
Aug 17, 2022
Diabetic Ketoacidosis Trial in Colombes (Insulin 0.05 IU/kg/h, Insulin 0.10 IU/kg/h)
Recruiting
- Diabetic Ketoacidosis
- Insulin 0.05 IU/kg/h
- Insulin 0.10 IU/kg/h
-
Colombes, FranceLouis Mourier Hospital
Jan 19, 2023
Stomach Cancer, Gastric Cancer Trial in Houston (drug, radiation, procedure)
Completed
- Stomach Cancer
- Gastric Cancer
- 5-Fluorouracil
- +4 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jan 29, 2020
HIV, Tuberculosis Trial in Worldwide (Levonorgestrel (LNG))
Completed
- HIV Infections
- Tuberculosis
- Levonorgestrel (LNG)
-
Chicago, Illinois
- +17 more
Dec 22, 2021
Dose Optimization of Rivaroxaban Combined With Rifampicin
Recruiting
- Infections
-
Nanjing, Jiangsu, ChinaThe Affiliated Nanjing Drum Tower Hospital of Nanjing University
Dec 17, 2022
Advanced Solid Tumor Trial in Nijmegen (PRECIOUS-01)
Recruiting
- Advanced Solid Tumor
-
Nijmegen, Gelderland, NetherlandsRadboudumc
Oct 26, 2022
Migraine, Migraine With Aura, Migraine Without Aura Trial in Miami (Dihydroergotamine)
Completed
- Migraine
- +2 more
-
Miami, FloridaQuotient Sciences Miami Inc.
Apr 13, 2022
Healthy Male Volunteers Trial in Shanghai (HLX14, EU-Prolia®, US-Prolia®)
Recruiting
- Healthy Male Volunteers
- HLX14
- +3 more
-
Shanghai, Shanghai, ChinaHuashan Hospital,Fudan University
Jun 27, 2022
Immunogenicity of BNT162b2 Covid-19 Vaccine in Elderly People
Completed
- Immunogenicity, Vaccine
-
Thessaloníki, Thessaloniki, GreeceG. Gennimatas General Hospital
Aug 3, 2022
Healthy Trial in Changsha (ASC42, Placebo)
Completed
- Healthy
- ASC42
- Placebo
-
Changsha, Hunan, ChinaXiangya Boai Rehabilitation Hospital
Jun 28, 2022
Malignant Solid Tumors Trial in Hangzhou (Genakumab)
Recruiting
- Malignant Solid Tumors
-
Hangzhou, Zhejiang, ChinaZhejiang Cancer Hospital
Jul 3, 2022
Influenza, Influenza Immunization Trial in United States (Influenza Hemagglutinin mRNA vaccine, Quadrivalent Recombinant
Completed
- Influenza
- Influenza Immunization
- Influenza Hemagglutinin mRNA vaccine
- Quadrivalent Recombinant Influenza Vaccine
-
Rolling Hills Estates, California
- +19 more
Oct 31, 2023
Covid19 Trial in Ankara (SARS-CoV-2 VLP Vaccine, Placebo)
Completed
- Covid19
- SARS-CoV-2 VLP Vaccine
- Placebo
-
Ankara, TurkeyDr. Abdurahman Yurtaslan Ankara Oncology Training and Research H
May 24, 2022
SAPHO Syndrome Trial in Warsaw (Etanercept, Placebo)
Recruiting
- SAPHO Syndrome
- Etanercept
- Placebo
-
Warsaw, Mazowieckie, PolandCentrum Wsparcia Badań Klinicznych
Aug 29, 2023
Obesity, Critical Illness Trial in Chicago (Imipenem/Cilastatin/Relebactam 1.25g)
Enrolling by invitation
- Obesity
- Critical Illness
- Imipenem/Cilastatin/Relebactam 1.25g
-
Chicago, IllinoisUniversity of Illinois at Chicago
May 18, 2022
Nasopharyngeal Carcinoma Trial in Nanning (endostar, DDP, IMRT)
Completed
- Nasopharyngeal Carcinoma
- endostar
- +2 more
-
Nanning, Guangxi, ChinaThe First Affiliated Hospital of Guangxi Medical University
Jan 30, 2022
AML, Adult Trial in Berne (HDM201, Midostaurin)
Terminated
- AML, Adult
-
Berne, SwitzerlandDepartement of Medical Oncology, University Hospital Berne
Oct 3, 2022
Colorectal Cancer Metastatic, Colorectal Cancer Trial in Baltimore (Therasphere Therapy)
Active, not recruiting
- Colorectal Cancer Metastatic
- Colorectal Cancer
- Therasphere Therapy
-
Baltimore, MarylandThe Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Jan 26, 2022
Advanced Solid Tumors Trial in France, United States (IPH5401 and Durvalumab)
Terminated
- Advanced Solid Tumors
- IPH5401 and Durvalumab
-
Louisville, Kentucky
- +11 more
Jan 12, 2022
Migraine Trial in Japan (Rimegepant 25 MG, Rimegepant 75 MG, Placebo)
Recruiting
- Migraine
- Rimegepant 25 MG
- +2 more
-
Ichikawa-shi, Chiba, Japan
- +43 more
Aug 16, 2022
Solid Tumor Trial in Italy, United States (Derazantinib low dose range, Derazantinib middle dose range, Derazantinib high dose
Completed
- Solid Tumor
- Derazantinib low dose range
- +3 more
-
Scottsdale, Arizona
- +11 more
Mar 7, 2022
Small Renal Masses (SRM) Trial in Hamilton (Radiofrequency Ablation, Stereotactive body radiation therapy)
Active, not recruiting
- Small Renal Masses (SRM)
- Radiofrequency Ablation
- Stereotactive body radiation therapy
-
Hamilton, Ontario, CanadaMcMaster Institute of Urology - St. Joseph's Healthcare Hamilton
Dec 14, 2021